veMico Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $33.1M

  • Investors
  • 1

veMico General Information

Description

Operator of a biotechnology company intended to extend healthy living by slowing down the aging process. The company uses artificial intelligence and synthetic biology to identify and advance promising molecules encoded in gut microbial DNA, enabling medical professionals to harness the power of microbiomes to promote gut health and overall well-being.

Contact Information

Website
www.vemico.co.uk
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Amelia House
  • Crescent Road, West Sussex
  • Worthing BN11 1RL
  • England, United Kingdom
Primary Industry
Biotechnology
Vertical(s)
Climate Tech, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • Amelia House
  • Crescent Road, West Sussex
  • Worthing BN11 1RL
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

veMico Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 24-Dec-2021 $33.1M Completed Generating Revenue
1. Accelerator/Incubator 20-Sep-2019 Completed Generating Revenue
To view veMico’s complete valuation and funding history, request access »

veMico Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

veMico Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202200069-D0 Compositions and methods for immunomodulation via control of intestinal microbiome Inactive 05-Jan-2022
EP-4460371-A1 Compositions and methods for immunomodulation via control of intestinal microbiome Pending 05-Jan-2022
GB-202101789-D0 Use of bifidobacterium breve, extract or polysac-charide thereform for antiaging, antiinflammation and hormonal regulation Inactive 10-Feb-2021
GB-202001534-D0 Use of bifidobacterium breve, extract or polysac-charide thereform for antigaing, antiinflammation and hormonal regualtion Inactive 05-Feb-2020
GB-202000717-D0 Vmk therapeutics Inactive 17-Jan-2020
To view veMico’s complete patent history, request access »

veMico Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

veMico Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
SOSV Venture Capital Minority
To view veMico’s complete investors history, request access »

Ready to get started?

Request a free trial

veMico FAQs

  • When was veMico founded?

    veMico was founded in 2018.

  • Where is veMico headquartered?

    veMico is headquartered in Worthing, United Kingdom.

  • What is the size of veMico?

    veMico has 3 total employees.

  • What industry is veMico in?

    veMico’s primary industry is Biotechnology.

  • Is veMico a private or public company?

    veMico is a Private company.

  • What is veMico’s current revenue?

    The current revenue for veMico is .

  • How much funding has veMico raised over time?

    veMico has raised $33.3M.

  • Who are veMico’s investors?

    SOSV has invested in veMico.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »